Bevacizumab or laser for aggressive posterior retinopathy of prematurity

PURPOSE: The purpose of this study was to report the rate of reactivation and structural outcome, after the laser or bevacizumab treatment for aggressive posterior retinopathy of prematurity (APROP). METHODS: Retrospective chart review was conducted on consecutive infants with APROP treated with (1)...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Taiwan J Ophthalmol
Asıl Yazarlar: Blair, Michael, Gonzalez, Jose Maria Garcia, Snyder, Laura, Schechet, Sidney, Greenwald, Mark, Shapiro, Michael, Rodriguez, Sarah Hilkert
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Medknow Publications & Media Pvt Ltd 2018
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6302568/
https://ncbi.nlm.nih.gov/pubmed/30637196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/tjo.tjo_69_18
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller